Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome
NCT06437210
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Post-COVID-19 Syndrome
COVID-19
Dyspnea
Fatigue
Cough
Inflammation
Interventions
DIETARY_SUPPLEMENT:
Viusid Oral Solution
DIETARY_SUPPLEMENT:
Placebo
Sponsor
Catalysis SL